Biosimilars/Follow-on-Biologics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biosimilars/Follow-on-Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Human Growth Hormone Erythropoietin Monoclonal Antibodies Insulin Interferon Granulocyte-Colony Stimulating Factor Peptide Others Segment by Application Blood Disorders Oncology Diseases Chronic and Autoimmune Diseases Growth Hormone Deficiencies Others By Company Novartis Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Group Biogen idec, Inc. Genentech (Roche Group) By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
1 Study Coverage 1.1 Biosimilars/Follow-on-Biologics Product Introduction 1.2 Market by Type 1.2.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Human Growth Hormone 1.2.3 Erythropoietin 1.2.4 Monoclonal Antibodies 1.2.5 Insulin 1.2.6 Interferon 1.2.7 Granulocyte-Colony Stimulating
